I first wrote about my thoughts on AMGN in a CotD post a week ago. In that post, I highlighted the importance of the $90 breakout level, stating my view going forward: Now that the …
Continue readingAMGN
Amgen broke out to an all-time high today, which is quite a feat for a $70 billion market cap biotechnology company that has had numerous strong rallies over the past 20 years. Amgen is one …
Continue readingDan and I have been debating the merits of the Staples sector for the past week. Dan’s been harping on the recent weakness of some of the former darling safe haven names, like KO or …
Continue reading